跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
(S)-crizotinib
首页
药物
(S)-crizotinib
(S)-crizotinib
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Crizotinib derivative as well as preparation method and application thereof
申请人: UNIV ZHEJIANG SHUREN
优先权: 2018
CN
Novel synthesis method of crizotinib intermediate
申请人: NANJING ANHUAI INNOVATIVE DRUG RES INSTITUTE CO LTD
优先权: 2020
CN
TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION USING (S)-CRIZOTINIB
申请人: VANDA PHARMACEUTICALS INC
优先权: 2022
US
Application of crizotinib as well as analogue and medicinal salt thereof in preparation of medicine for treating ferroptosis related diseases
申请人: UNIV CHONGQING MEDICAL
优先权: 2024
CN
Synthesis method of crizotinib intermediate
申请人: CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD
优先权: 2024
CN
Preparation method of crizotinib
申请人: GUANGZHOU KERUITE PHARMACEUTICAL CO LTD
优先权: 2026
CN
药物
反馈